$80,000 of GOODRX lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues regarding lower prescription drug prices for patients Issues regarding lower prescription drug prices for patients"
You can find more data on corporate lobbying on Quiver Quantitative.
GDRX Hedge Fund Activity
We have seen 80 institutional investors add shares of GDRX stock to their portfolio, and 72 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LSV ASSET MANAGEMENT added 2,156,031 shares (+76.3%) to their portfolio in Q1 2026, for an estimated $4,225,820
- MILLENNIUM MANAGEMENT LLC removed 1,610,843 shares (-98.4%) from their portfolio in Q1 2026, for an estimated $3,157,252
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 1,488,137 shares (-99.0%) from their portfolio in Q1 2026, for an estimated $2,916,748
- CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. removed 1,156,003 shares (-82.7%) from their portfolio in Q1 2026, for an estimated $2,265,765
- MORGAN STANLEY removed 788,136 shares (-70.5%) from their portfolio in Q1 2026, for an estimated $1,544,746
- AQR CAPITAL MANAGEMENT LLC added 643,799 shares (+55.6%) to their portfolio in Q1 2026, for an estimated $1,261,846
- MOORE CAPITAL MANAGEMENT, LP added 590,851 shares (+63.0%) to their portfolio in Q1 2026, for an estimated $1,158,067
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
GDRX Price Targets
Multiple analysts have issued price targets for $GDRX recently. We have seen 6 analysts offer price targets for $GDRX in the last 6 months, with a median target of $3.25.
Here are some recent targets:
- Daniel Grosslight from Citigroup set a target price of $4.0 on 05/14/2026
- Charles Rhyee from TD Cowen set a target price of $4.0 on 05/11/2026
- Stan Berenshteyn from Wells Fargo set a target price of $3.5 on 03/04/2026
- Eric Sheridan from Goldman Sachs set a target price of $2.5 on 03/02/2026
- Steven Valiquette from Mizuho set a target price of $3.0 on 02/27/2026
- Glen Santangelo from Jefferies set a target price of $2.75 on 01/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
